VNRX

Volitionrx Limited · AMEX

Sector Health Technology
Industry Medical Specialties
Website volition.com
Employees(FY) 114
ISIN US9286611077

Performance

-4.93%

1W

+24.19%

1M

-25.96%

3M

+1.32%

6M

+7.39%

YTD

-50.96%

1Y

Profile

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 worldwide. It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company is based in Henderson, Nevada.

Advanced Technical Analysis

Technical Analysis of VNRX 2024-05-10

Overview:

In analyzing the technical indicators for VNRX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day MA has been consistently below the closing prices, in...

See more ...

Recent News & Updates

2024-05-14 15:01
VolitionRX Ltd (VNRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances and ...(Yahoo Finance)
2024-05-13 05:11
VolitionRX: Q1 Earnings Snapshot(Yahoo Finance)
2024-05-13 04:10
VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update(Prnewswire)
2024-05-07 20:00
VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update(Prnewswire)
2024-04-22 20:00
Nu.Q Vet Cancer Test launched in-clinic in U.S. and Europe through Antech(Prnewswire)
2024-03-27 00:31
VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript(Yahoo Finance)
2024-03-25 04:10
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update(Prnewswire)
2024-03-20 20:30
VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update(Prnewswire)
2024-03-19 20:30
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan(Yahoo Finance)
2024-03-19 04:30
Volition appoints Dr Andrew Retter as Chief Medical Officer(Yahoo Finance)
2024-02-01 19:00
Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar(Yahoo Finance)
2024-01-17 15:54
Next Big Thing: 3 Biotech Stocks to Watch for Groundbreaking Advances(Yahoo Finance)
2024-01-03 19:00
Volition Issues Business Review 2023(Yahoo Finance)
2023-12-04 21:25
Sidoti Events, LLC's Virtual December Small-Cap Conference(Yahoo Finance)
2023-12-04 19:00
VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre(Yahoo Finance)
2023-11-15 20:15
VolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call Transcript(Yahoo Finance)
2023-11-14 16:08
VolitionRX: Q3 Earnings Snapshot(Yahoo Finance)
2023-11-14 03:10
VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update(Yahoo Finance)
2023-11-07 19:00
VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update(Yahoo Finance)
2023-11-05 17:24
Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland(Yahoo Finance)
2023-11-01 20:19
VNRX: Breakthrough Cancer Detection Method Disclosed at ESMO and in a Webinar - preliminary proof of concept work indicates simple blood test should be able to detect several types of cancer, potentially at Stages I & II(Yahoo Finance)
2023-10-22 20:00
Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage Cancer(Yahoo Finance)
2023-10-18 20:00
Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock(Yahoo Finance)
2023-10-18 00:00
US Ambassador Adler visits Belgian Volition(Yahoo Finance)
2023-10-15 20:00
Volition Presents Three Cancer Detection Abstracts at ESMO 2023(Yahoo Finance)
2023-10-12 20:00
Volition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis(Yahoo Finance)
2023-10-01 20:00
Volition to Reveal New Cancer Detection Method Insights at Upcoming Webinar(Yahoo Finance)
2023-09-12 20:00
Volition Hosts Key Opinion Leader Roundtable on Sepsis Management(Yahoo Finance)
2023-08-24 16:30
VolitionRx (VNRX): Review of 2Q 2023; Distribution Footprint of Nu.Q Vet Cancer Test is expanding. Prolific Schedule of Clinical Papers & Posters.(Yahoo Finance)
2023-08-14 05:27
VolitionRX: Q2 Earnings Snapshot(Yahoo Finance)

Page 1 of 4

previousnext